← Back to Search

Behavioral Intervention

Robot + tDCS for Cerebral Palsy (RoboCP Trial)

Phase 2
Waitlist Available
Led By Sean P Dukelow, MD, PhD
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
confirmed diagnosis of hemiparetic cerebral palsy due to unilateral perinatal stroke
age 6-18 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change between pre-assessment (within 1 week of starting intervention) and post-assessment (within 1 week of completing intervention)
Awards & highlights

RoboCP Trial Summary

This trial is testing if adding electrical stimulations to robot-assisted therapy can help improve movement in children with half- paralysis due to cerebral palsy.

Eligible Conditions
  • Cerebral Palsy
  • Perinatal Stroke

RoboCP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

RoboCP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change between pre-assessment (within 1 week of starting intervention) and post-assessment (within 1 week of completing intervention)
This trial's timeline: 3 weeks for screening, Varies for treatment, and change between pre-assessment (within 1 week of starting intervention) and post-assessment (within 1 week of completing intervention) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Reaching Accuracy
Secondary outcome measures
Assisting Hand Assessment
Box and Block Assessment
Purdue Pegboard
+1 more

RoboCP Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Robot + tDCSExperimental Treatment1 Intervention
10 sessions of 1.5 hrs of robotic therapy within a 3 week period, with 20 minutes of 1mA cathodal tDCS applied to the contralesional M1 area during first 20 minutes of robotic therapy. Robotic therapy will be conducted using the Kinarm Exoskeleton robot and use games to target unilateral and bilateral motor and sensory impairments.
Group II: Robot + sham tDCSPlacebo Group1 Intervention
10 sessions of 1.5 hrs of robotic therapy within a 3 week period with 20 minutes of SHAM tDCS applied during the first 20 minutes of the robotic therapy. As with experimental arm, electrode will be placed on contralesional M1. Current will ramp up and then immediately ramp down to simulate the cutaneous sensations felt with actual tDCS. Robotic therapy will be delivered with Kinarm Exoskeleton robot and use games to target unilateral and bilateral motor and sensory impairments.

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
780 Previous Clinical Trials
841,714 Total Patients Enrolled
8 Trials studying Cerebral Palsy
302 Patients Enrolled for Cerebral Palsy
Sean P Dukelow, MD, PhDPrincipal InvestigatorUniversity of Calgary

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~3 spots leftby Mar 2025